TP53 and ovarian carcinoma: Because of the mutation of TP53 in platinum-resistant epithelial ovarian cancer (EOC) and the acetylation effect of aspirin, we hypothesized that aspirin exerts an anticancer effect on EOC through the acetylation of p53.